Jul 26, 2021
The pharma companies are juggling multiple priorities like improving R&D, establishing a presence in global markets, and investing in digital transformation initiatives to move beyond the pill, find new revenue streams, and handle changing customer’s expectations for personalization. Pandemic further complicated the issues with delayed product launches, reduced in-person sales visit potential, supply chain disruption, and delays in drug commercialization. So how are the pharma industry players dealing with this perfect storm? What’s the road to relevant, profitable, and future-ready pharma?
Guest: Minori Hara
Title: Chief Information Officer and Head of Digital & IT Division, Santen Pharmaceutical
For more details and related content: